1 Systolic Blood Pressure and Cardiovascular Outcomes During Treatment of Hypertension American Journal of Medicine, May 24, 2013 Evidence Based Medicine
2 A double-blind placebo-controlled clinical evaluation of MultiStem for the treatment of ischemic stroke International Journal of Stroke, May 24, 2013
3 Cost-effectiveness of apixaban, dabigatran, rivaroxaban, and warfarin for stroke prevention in atrial fibrillation Stroke, May 29, 2013
4 Effect of addition of clopidogrel to aspirin on stroke incidence: Meta-analysis of randomized trials International Journal of Stroke, May 23, 2013
5 Increased consumption of fruit and vegetables for the primary prevention of cardiovascular diseases Cochrane Reviews, June 6, 2013 Evidence Based Medicine
6 Paracetamol (Acetaminophen) in stroke 2 (PAIS 2): Protocol for a randomized, placebo-controlled, double-blind clinical trial to assess the effect of high-dose paracetamol on functional outcome in patients with acute stroke and a body temperature of 36·5°C or above International Journal of Stroke, May 28, 2013
7 Mediterranean diet and stroke, cognitive impairment, depression: A meta-analysis Annals of Neurology , May 31, 2013
8 Triple Therapy With Aspirin, Prasugrel, and Vitamin K Antagonists in Patients With Drug-Eluting Stent Implantation and an Indication for Oral Anticoagulation JACC - Journal of the American College of Cardiology, May 20, 2013
9 Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicentre randomised controlled trial The Lancet, May 31, 2013 Evidence Based Medicine
10 Blood-pressure targets in patients with recent lacunar stroke: The SPS3 randomised trial The Lancet, May 29, 2013 Evidence Based Medicine
Sponsor
Register now to view all the MDLinx contents (FREE)!
Login
Sponsor
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close
Sponsor